Q34048 NADH-ubiquinone oxidoreductase chain 4 MolNFT, Molecular NFT on GenesisL1

NADH-ubiquinone oxidoreductase chain 4

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeia4f75cdhb746mdpmhbh5pdhukd3fyajy66zhl2aeyxceeosooilu/metadata.json

IPFS of structure file:

bafybeiencirhwyihdoewltwpmydntojfaq4al6s7hsjshugwwvbztqxpd4/AF-Q34048-F1-model_v2.pdb

First NFT owner address (eip-55):

0x0B6BE64F769E0c8265d47e5d13B7B413c2B8eB6C

First NFT owner address (bech32):

genesis1pd47vnmkncxgyew50ew38da5z0pt36mvwcy6lw

Current NFT ID #273266 owner (web3):

0x0B6BE64F769E0c8265d47e5d13B7B413c2B8eB6C

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
273266
Accession (UniProt):
Q34048
Name::
NADH-ubiquinone oxidoreductase chain 4
Experimental Method:
Predicted structure
Sequence source:
CERATITIS CAPITATA

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q34048 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q34048|NU4M_CERCA NADH-ubiquinone oxidoreductase chain 4 OS=Ceratitis capitata OX=7213 GN=ND4 PE=3 SV=2 MLKLILMMIFISPICFMQGLFWMVHNLLFVITFVLILMNFCLNYFVNISYFMGFDVLSYGLILLSFWICSLMIVASESVNKYNNYKNLFLFNVLMLLIFLVLTFSSMNLFMFYLFFESSLIPTLFLILGWGYQPERLQAGVYLLFYTLLVSLPLLVGIFYLYKNCNTMNFYLLSNYMFNCNLLYLAMILAFLVKMPMFLVHLWLPKAHVEAPVSGSMILAGIMLKLGGYGLLAVFSFLQLIGLKYNYIWVSISLIGGVLISLVCLRQTDLKALIAYSSVAHMGIVLGGLMTLSYWGLSGSYTLMIGHGLCSSGLFCLANITYERLGSRSLLINKGLLNFMPSMTLWWFLLSVCNMAAPPSLNLLGEISLLNSIVSWSWLTMISLSFLSFFSAAYTLYLYAYSQHGKIFSGVYSFSGGNIREYFLLFLHWFPLNLLILKSEVCLFWI

Q34048 AF NFT

MOLNFT AF v1

NFT data

MOLNFT Q34048 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience